ArticleFrontiers in neuroscience2025
Inhibiting aberrant seizure-induced neurogenesis by temozolomide improves cognitive impairments associated with long-term amygdala kindling.
Article in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- TNF-mediated hilar interneuron loss and aberrant granule cell migration are associated with chronic cognitive deficits following TBI.Brain, behavior, and immunity · 2026Article
- Post-ischemic modification of neurogenesis and oligodendrogenesis in rodent models.Frontiers in neural circuits · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the adult dentate gyrus, new neurons are continuously generated and integrated into the existing circuitry where they play a crucial role in maintaining important functions related to learning and memory. Seizures not only robustly increase levels of hippocampal neurogenesis but can also induce aberrant migration and functional development of these new neurons, which has been hypothesized to promote network excitability and epileptogenesis. However, the contribution of new neurons to the development of epilepsy-related cognitive impairments remain unclear. Here, we investigated whether suppressing this abnormal elevation in neurogenesis that occur with seizures could prevent the emergence of cognitive dysfunction and behavioral deficits associated with chronic epilepsy. Using the long-term amygdala kindling model (consisting of 99 electrical stimulations), we demonstrate that initiating cyclic treatment with the DNA-alkylating agent temozolomide (TMZ) during a period of heightened neurogenic activity can reduce aberrant hippocampal neurogenesis and rescue impairments in a contextual fear discrimination task known to depend on functional neurogenesis. In addition, TMZ treatment also prevented object recognition memory deficits after kindling. Together, our findings suggest kindled seizures trigger the production of new neurons that can effectively rewire and interfere with hippocampal circuit function which can contribute to the development of chronic cognitive and behavioral deficits as seen in both patients with epilepsy and other rodent models. Thus, strategies that can selectively reduce aberrant adult neurogenesis may serve as a novel approach to treat cognitive deficits associated with epilepsy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.